Dr. James Carmody, MD

NPI: 1598927030
Total Payments
$17,971
2023 Payments
$3,240
Companies
10
Transactions
22

Payment Breakdown by Category

Other$12,030 (66.9%)
Consulting$5,170 (28.8%)
Travel$562.16 (3.1%)
Food & Beverage$208.93 (1.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $12,030 6 66.9%
Consulting Fee $5,170 3 28.8%
Travel and Lodging $562.16 2 3.1%
Food and Beverage $208.93 11 1.2%

Top Paying Companies

Company Total Records Latest Year
Horizon Therapeutics plc $11,880 5 $0 (2023)
Retrophin, Inc. $5,591 5 $0 (2018)
Alexion Pharmaceuticals, Inc. $191.64 4 $0 (2022)
C. R. Bard, Inc. & Subsidiaries $170.00 1 $0 (2021)
Mallinckrodt LLC $34.67 1 $0 (2017)
Genentech USA, Inc. $32.77 2 $0 (2017)
Relypsa, Inc. $25.00 1 $0 (2017)
Azurity Pharmaceuticals, Inc. $17.78 1 $0 (2021)
Amgen Inc. $15.20 1 $0 (2018)
Silvergate Pharmaceuticals, Inc. $12.83 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2023 $3,240 1 Horizon Therapeutics plc ($3,240)
2022 $2,898 2 Horizon Therapeutics plc ($2,880)
2021 $4,688 4 Horizon Therapeutics plc ($4,500)
2020 $1,260 1 Horizon Therapeutics plc ($1,260)
2019 $162.18 2 Alexion Pharmaceuticals, Inc. ($162.18)
2018 $5,618 7 Retrophin, Inc. ($5,591)
2017 $105.27 5 Mallinckrodt LLC ($34.67)

All Payment Transactions

22 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/24/2023 Horizon Therapeutics plc PROCYSBI (Drug) Honoraria Cash or cash equivalent $3,240.00 General
Category: PROCYSBI
04/04/2022 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $17.92 General
Category: Rare Disease
03/25/2022 Horizon Therapeutics plc PROCYSBI (Drug) Honoraria Cash or cash equivalent $2,880.00 General
Category: PROCYSBI
10/01/2021 Horizon Therapeutics plc PROCYSBI (Drug) Honoraria Cash or cash equivalent $2,160.00 General
Category: PROCYSBI
09/14/2021 Azurity Pharmaceuticals, Inc. Epaned (Drug), Qbrelis, Katerzia Food and Beverage Cash or cash equivalent $17.78 General
Category: pediatric hypertension
04/01/2021 Horizon Therapeutics plc PROCYSBI (Drug) Honoraria Cash or cash equivalent $2,340.00 General
Category: PROCYSBI
03/08/2021 C. R. Bard, Inc. & Subsidiaries Consulting Fee Cash or cash equivalent $170.00 General
06/17/2020 Horizon Therapeutics plc PROCYSBI (Drug) Honoraria Cash or cash equivalent $1,260.00 General
Category: PROCYSBI
12/19/2019 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Drug) Food and Beverage In-kind items and services $12.18 General
Category: Immunology
06/27/2019 Alexion Pharmaceuticals, Inc. Soliris (Drug) Honoraria Cash or cash equivalent $150.00 General
Category: Immunology
06/14/2018 Retrophin, Inc. (815) Thiola (Drug) Consulting Fee Cash or cash equivalent $2,500.00 General
Category: Kidney Stones
06/14/2018 Retrophin, Inc. (815) Thiola (Drug) Travel and Lodging Cash or cash equivalent $50.75 General
Category: Kidney Stones
06/14/2018 Retrophin, Inc. (815) Thiola (Drug) Food and Beverage Cash or cash equivalent $29.04 General
Category: Kidney Stones
06/08/2018 Retrophin, Inc. Consulting Fee Cash or cash equivalent $2,500.00 General
05/01/2018 Amgen Inc. Parsabiv (Biological) Food and Beverage In-kind items and services $15.20 General
Category: Nephrology
04/19/2018 Retrophin, Inc. (815) Thiola (Drug) Travel and Lodging Cash or cash equivalent $511.41 General
Category: Kidney Stones
01/03/2018 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $11.54 General
Category: Immunology
09/13/2017 Silvergate Pharmaceuticals, Inc. Epaned (Drug), Qbrelis Food and Beverage In-kind items and services $12.83 General
Category: cardiology
05/24/2017 Genentech USA, Inc. Nutropin AQ (Biological) Food and Beverage In-kind items and services $14.92 General
Category: Metabolism & Primary Care
04/26/2017 Relypsa, Inc. Veltassa (Drug) Food and Beverage In-kind items and services $25.00 General
Category: Hyperkalemia
03/24/2017 Mallinckrodt LLC ACTHAR (Biological) Food and Beverage In-kind items and services $34.67 General
Category: AUTOIMMUNE AND RARE DISEASE
01/17/2017 Genentech USA, Inc. Nutropin AQ (Biological) Food and Beverage In-kind items and services $17.85 General
Category: Metabolism & Primary Care

About Dr. James Carmody, MD

Dr. James Carmody, MD is a Pediatrics healthcare provider based in Norfolk, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2008. The National Provider Identifier (NPI) number assigned to this provider is 1598927030.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Carmody, MD has received a total of $17,971 in payments from pharmaceutical and medical device companies, with $3,240 received in 2023. These payments were reported across 22 transactions from 10 companies. The most common payment nature is "Honoraria" ($12,030).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Pediatric Nephrology
  • Location Norfolk, VA
  • Active Since 06/26/2008
  • Last Updated 02/18/2019
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1598927030

Products in Payments

  • PROCYSBI (Drug) $11,880
  • (815) Thiola (Drug) $3,091
  • Soliris (Drug) $150.00
  • ACTHAR (Biological) $34.67
  • Nutropin AQ (Biological) $32.77
  • Epaned (Drug) $30.61
  • Veltassa (Drug) $25.00
  • ULTOMIRIS (Biological) $17.92
  • Parsabiv (Biological) $15.20
  • ULTOMIRIS (Drug) $12.18
  • SOLIRIS (Drug) $11.54

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Norfolk